Editas Medicine, Inc. (EDIT)
2.435
-0.04
(-1.81%)
USD |
NASDAQ |
Jun 11, 16:00
2.46
+0.02
(+1.03%)
After-Hours: 20:00
Editas Medicine Debt to Equity Ratio : 16.33 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 16.33 |
| December 31, 2025 | 2.811 |
| September 30, 2025 | 5.852 |
| June 30, 2025 | 4.055 |
| March 31, 2025 | 0.4988 |
| December 31, 2024 | 0.2609 |
| September 30, 2024 | 0.2191 |
| June 30, 2024 | 0.1668 |
| March 31, 2024 | 0.116 |
| December 31, 2023 | 0.1047 |
| September 30, 2023 | 0.096 |
| June 30, 2023 | 0.093 |
| March 31, 2023 | 0.117 |
| December 31, 2022 | 0.1218 |
| September 30, 2022 | 0.0514 |
| June 30, 2022 | 0.0435 |
| March 31, 2022 | 0.0452 |
| December 31, 2021 | 0.0476 |
| September 30, 2021 | 0.0489 |
| June 30, 2021 | 0.0493 |
| March 31, 2021 | 0.0453 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.0664 |
| September 30, 2020 | 0.0605 |
| June 30, 2020 | 0.0675 |
| March 31, 2020 | 0.1159 |
| December 31, 2019 | 0.1108 |
| September 30, 2019 | 0.0841 |
| June 30, 2019 | 0.0903 |
| March 31, 2019 | 0.0846 |
| December 31, 2018 | 0.1373 |
| September 30, 2018 | 0.1457 |
| June 30, 2018 | 0.1424 |
| March 31, 2018 | 0.1341 |
| December 31, 2017 | 0.1967 |
| September 30, 2017 | 0.1894 |
| June 30, 2017 | 0.2642 |
| March 31, 2017 | 0.237 |
| December 31, 2016 | 0.335 |
| September 30, 2016 | 0.1883 |
| June 30, 2016 | 0.121 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Precision BioSciences, Inc. | 0.3741 |
| Black Diamond Therapeutics, Inc. | 0.1714 |
| Agenus, Inc. | -1.376 |
| Amgen, Inc. | 6.238 |
| BioCryst Pharmaceuticals, Inc. | -1.549 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 149.34M |
| Total Liabilities (Quarterly) | 144.93M |
| Shareholders Equity (Quarterly) | 4.408M |
| Current Ratio | 3.219 |
| Net Debt Paydown Yield | -3.06% |